S R Confer

928 total citations
10 papers, 701 citations indexed

About

S R Confer is a scholar working on Hepatology, Epidemiology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, S R Confer has authored 10 papers receiving a total of 701 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Hepatology, 5 papers in Epidemiology and 5 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in S R Confer's work include MRI in cancer diagnosis (4 papers), Hepatocellular Carcinoma Treatment and Prognosis (4 papers) and Liver Disease Diagnosis and Treatment (4 papers). S R Confer is often cited by papers focused on MRI in cancer diagnosis (4 papers), Hepatocellular Carcinoma Treatment and Prognosis (4 papers) and Liver Disease Diagnosis and Treatment (4 papers). S R Confer collaborates with scholars based in United States. S R Confer's co-authors include R L Baron, Gerald D. Dodd, Michael P. Federle, Mark S. Peterson, James H. Oliver, MP Federle, Kuni Ohtomo, Paul J. Chang, J. Wallis Marsh and R L Baron and has published in prestigious journals such as Radiology, Radiologic Clinics of North America and PubMed.

In The Last Decade

S R Confer

10 papers receiving 681 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
S R Confer United States 10 368 298 186 146 106 10 701
Sam Stuart United Kingdom 11 249 0.7× 87 0.3× 103 0.6× 268 1.8× 70 0.7× 28 603
W. Phillip Law Australia 9 150 0.4× 164 0.6× 97 0.5× 59 0.4× 72 0.7× 24 590
Chen‐Te Chou Taiwan 14 370 1.0× 244 0.8× 206 1.1× 206 1.4× 37 0.3× 53 698
Ahmad Parvinian United States 18 520 1.4× 371 1.2× 67 0.4× 415 2.8× 55 0.5× 51 758
James J. Pollard United States 14 119 0.3× 100 0.3× 24 0.1× 294 2.0× 119 1.1× 38 573
Franklin Greif Israel 13 313 0.9× 74 0.2× 18 0.1× 575 3.9× 112 1.1× 39 802
Saravanan Namasivayam United States 9 102 0.3× 55 0.2× 237 1.3× 97 0.7× 46 0.4× 11 481
Whitney Limm United States 10 308 0.8× 190 0.6× 29 0.2× 190 1.3× 79 0.7× 20 537
Anthie Papadopoulou United Kingdom 10 98 0.3× 199 0.7× 17 0.1× 192 1.3× 187 1.8× 26 502
Songjiang Huang China 13 315 0.9× 216 0.7× 20 0.1× 143 1.0× 89 0.8× 42 604

Countries citing papers authored by S R Confer

Since Specialization
Citations

This map shows the geographic impact of S R Confer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S R Confer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S R Confer more than expected).

Fields of papers citing papers by S R Confer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S R Confer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S R Confer. The network helps show where S R Confer may publish in the future.

Co-authorship network of co-authors of S R Confer

This figure shows the co-authorship network connecting the top 25 collaborators of S R Confer. A scholar is included among the top collaborators of S R Confer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S R Confer. S R Confer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Malluche, Hartmut H., Charles R. Swanepoel, Hanna Mawad, et al.. (2008). Improvements in renal osteodystrophy in patients treated with lanthanum carbonate for two years.. PubMed. 70(4). 284–95. 73 indexed citations
3.
Federle, MP, et al.. (1998). Frequency and effects of extravasation of ionic and nonionic CT contrast media during rapid bolus injection.. Radiology. 206(3). 637–640. 104 indexed citations
4.
Murakami, Takamichi, R L Baron, Michael P. Federle, et al.. (1996). Cirrhosis of the liver: MR imaging with mangafodipir trisodium (Mn-DPDP).. Radiology. 198(2). 567–572. 30 indexed citations
5.
Murakami, Takamichi, R L Baron, Mark S. Peterson, et al.. (1996). Hepatocellular carcinoma: MR imaging with mangafodipir trisodium (Mn-DPDP).. Radiology. 200(1). 69–77. 97 indexed citations
6.
Little, A, R L Baron, Mark S. Peterson, et al.. (1994). Optimizing CT portography: a prospective comparison of injection into the splenic versus superior mesenteric artery.. Radiology. 193(3). 651–655. 15 indexed citations
7.
Ohtomo, Kuni, R L Baron, Gerald D. Dodd, et al.. (1993). Confluent hepatic fibrosis in advanced cirrhosis: appearance at CT.. Radiology. 188(1). 31–35. 94 indexed citations
8.
Ohtomo, Kuni, R L Baron, Gerald D. Dodd, et al.. (1993). Confluent hepatic fibrosis in advanced cirrhosis: evaluation with MR imaging.. Radiology. 189(3). 871–874. 87 indexed citations
9.
Chambers, Theodore, et al.. (1993). Hepatic CT enhancement: a method to demonstrate reproducibility.. Radiology. 188(3). 627–631. 19 indexed citations
10.
Dodd, Gerald D., et al.. (1992). THORACIC AND ABDOMINAL MANIFESTATIONS OF LYMPHOMA OCCURRING IN THE IMMUNOCOMPROMISED PATIENT. Radiologic Clinics of North America. 30(3). 597–610. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026